A delegation from Vietnam’s Dai Nam Son Group arrived in South Korea on the 21st to explore the adoption of Seoul Yes Hospital’s spinal and joint care, stem cell therapy, and regenerative medicine systems, as well as to facilitate exchanges among medical staff.

The delegation, consisting of 10 members including DAI NAM SON Group Chairman Pham Dinh Huynh, Vice Chairman Ma Thi Kim Dao, and Vietnamese government officials, held working-level negotiations and toured Seoul Yes Hospital, pledging active future cooperation between the two organizations.

Founded in 1992, the DAI NAM SON Group is a company that has established branches throughout Vietnam based on its real estate business and produces and sells health foods and pharmaceuticals.

The event was attended by Dr. Lee Gil-yong, Chief Executive Director of Seoul Yes Hospital (a board-certified neurosurgeon) and a leading authority on endoscopic spine treatment in Korea, and Dr. Cho Seong-hoon (a board-certified emergency medicine specialist) and a pioneer in immunoregenerative therapy in Korea. They provided explanations regarding the hospital’s spine and joint treatment systems, as well as its stem cell and immunoregenerative therapy systems, and led a tour of the facility.

Director Lee Gil-yong stated, “This visit by the DAI NAM SON Group was arranged at their request to receive support for Seoul Yes Hospital’s medical systems and treatment expertise, with which they have maintained ongoing exchanges ahead of opening a 20-story hospital in the Can Tho region of Vietnam,” and He added, “Seoul Yes Hospital has promised to actively provide phased support for the medical systems and know-how it has accumulated over the years with a forward-looking attitude.”

Seoul Yes Hospital, which was selected as an international medical business consulting agency by the Korea Health Industry Development Institute last July and has been leading the way in the overseas expansion of domestic medical institutions, plans to use this visit by the DAI NAM SON Group as an opportunity to further promote the excellence of South Korean medical technology worldwide through more active overseas expansion and exchanges with foreign medical institutions.

Reporter Jang Jong-ho bellho@sportschosun.com